These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9470844)

  • 1. c-erbB-3 protein expression in ductal carcinoma in situ of the breast.
    Bobrow LG; Millis RR; Happerfield LC; Gullick WJ
    Eur J Cancer; 1997 Oct; 33(11):1846-50. PubMed ID: 9470844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.
    Inaji H; Koyama H; Motomura K; Noguchi S
    Breast Cancer Res Treat; 1996; 37(1):89-92. PubMed ID: 8750531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
    Suo Z; Emilsen E; Tveit KM; Nesland JM
    Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO; Corte MD; Junquera S; Bongera M; Rodriguez JC; Vizoso FJ
    Histopathology; 2007 Jun; 50(7):866-74. PubMed ID: 17543076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ distribution of oncogene products and growth factor receptors in breast carcinoma: c-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit.
    Kommoss F; Colley M; Hart CE; Franklin WA
    Mol Cell Probes; 1990 Feb; 4(1):11-23. PubMed ID: 1969111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
    Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
    Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
    Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
    Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and C-erbB-2 oncogene expression. Nottingham Breast Team.
    Evans AJ; Pinder SE; Ellis IO; Sibbering DM; Elston CW; Poller DN; Wilson AR
    Clin Radiol; 1994 Aug; 49(8):559-62. PubMed ID: 7955870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast.
    Lodato RF; Maguire HC; Greene MI; Weiner DB; LiVolsi VA
    Mod Pathol; 1990 Jul; 3(4):449-54. PubMed ID: 2170971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.
    Megha T; Ferrari F; Benvenuto A; Bellan C; Lalinga AV; Lazzi S; Bartolommei S; Cevenini G; Leoncini L; Tosi P
    J Clin Pathol; 2002 Jun; 55(6):461-6. PubMed ID: 12037031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid-tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation.
    Tsuda H; Morita D; Kimura M; Shinto E; Ohtsuka Y; Matsubara O; Inazawa J; Tamaki K; Mochizuki H; Tamai S; Hiraide H
    Cancer Sci; 2005 Jan; 96(1):48-53. PubMed ID: 15649255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].
    Yang M; Xu SP; Ao QL
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):257-61. PubMed ID: 23928534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
    Somerville JE; Clarke LA; Biggart JD
    J Clin Pathol; 1992 Jan; 45(1):16-20. PubMed ID: 1346789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of c-erbB-2 in in situ and in adjacent invasive ductal adenocarcinomas of the female breast.
    Maguire HC; Hellman ME; Greene MI; Yeh I
    Pathobiology; 1992; 60(3):117-21. PubMed ID: 1352687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-erbB-2 amplification in mammary carcinoma.
    Barnes DM
    J Cell Biochem Suppl; 1993; 17G():132-8. PubMed ID: 7911860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ.
    Schimmelpenning H; Eriksson ET; Pallis L; Skoog L; Cedermark B; Auer GU
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S48-52. PubMed ID: 1374218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cell size and Akt activation in HER-2/neu-overexpressing invasive ductal carcinoma of the breast.
    Sastre-Garau X; Genin P; Rousseau A; Al Ghuzlan A; Nicolas A; Fréneaux P; Rosty C; Sigal-Zafrani B; Couturier J; Thiery JP; Magdelénat H; Vincent-Salomon A
    Histopathology; 2004 Aug; 45(2):142-7. PubMed ID: 15279632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of c-erbB3 protein in primary breast carcinomas.
    Naidu R; Yadav M; Nair S; Kutty MK
    Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.